| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 08/13/2003 | CN1436079A Imidazopyridine and imidazopyrimidine antiviral agent |
| 08/13/2003 | CN1117751C Antiviral nucleoside analogues |
| 08/12/2003 | US6605725 Treating a central or peripheral nervous system disorder or condition through modulation of a voltage-dependent potassium channel |
| 08/12/2003 | US6605600 Diuretics |
| 08/12/2003 | US6605299 Releasable linkage and compositions containing same |
| 08/07/2003 | WO2003063876A2 Methods of treating patients suffering from movement disorders |
| 08/07/2003 | WO2003063800A2 8-heteroaryl xanthine adenosine a2b receptor antagonists |
| 08/07/2003 | WO2001073095A3 Preparation of deoxynucleosides |
| 08/07/2003 | US20030149060 A2A adenosine receptor antagonists |
| 08/07/2003 | US20030149059 Tetrahydropurinones and derivatives thereof as corticotropin releasing factor receptor ligands |
| 08/07/2003 | US20030149050 Inhibitors of inflammation and reperfusion injury and methods of use thereof |
| 08/07/2003 | CA2813048A1 Composition for use in treating patients suffering from movement disorder |
| 08/07/2003 | CA2443023A1 8-heteroaryl xanthine adenosine a2b receptor antagonists |
| 08/06/2003 | CN1434827A 新的哌啶和哌嗪衍生物 The new piperidine and piperazine derivatives |
| 07/31/2003 | WO2003062229A1 Process for producing dioxolane nucleoside analogues |
| 07/31/2003 | WO2003062212A1 Peptide nucleic acid oligomers from 1-benzenesulfonyl-3-amino acid side chain-4-(2-nucleobase(acetyl))-piperazin-2-ones |
| 07/31/2003 | US20030144532 Method of manufacture of 1,3-oxathiolane nucleosides |
| 07/31/2003 | US20030144508 Preparing a 2,6- halogenopurine using an inexpensive starting material. A process for preparing a 2,6-dihalogenopurine, comprising treating a 2-amino-6-halogenopurine having a protective group at 7th position or 9th position with a |
| 07/30/2003 | CN1433411A Chemical compounds |
| 07/30/2003 | CN1433312A Barbituric acid analogs as therapeutic agents |
| 07/29/2003 | US6600038 Carbamoyl tetrahydropyridine derivatives |
| 07/29/2003 | US6599918 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans |
| 07/24/2003 | US20030139428 Purine derivatives for treatment of gastrointestinal disorders, immunological disorders, neurological disorders |
| 07/24/2003 | US20030139427 Sedatives; vasodilation; antiinflammatory agents; cardiovascular disorders |
| 07/23/2003 | EP0822817B1 Use of (r)-penciclovir triphosphate for the manufacture of a medicament for the treatment of viral diseases |
| 07/23/2003 | EP0628044B1 Therapeutic nucleosides |
| 07/23/2003 | CN1115343C Process for prepn. of (1S,4R)-or (1R,4S)-4-(2-amino-6-chloro-9H-purin-9-yl) -2-cyclopentene-1-methanol |
| 07/23/2003 | CN1115152C Method for treating bronchitis with uridine triphosphates and related compounds |
| 07/22/2003 | US6596858 Process for the production of 2-halo-6-aminopurine derivatives |
| 07/22/2003 | US6596728 A pharmaceutical composition, comprising at least one compound or salt thereof as claimed in claim 1 and a polypeptides with excipients |
| 07/22/2003 | US6596726 Method of inhibiting epidermal growth factor by treating, with an effective inhibiting amount, a mammal, in need thereof inhibit the epidermal growth factor receptor and related receptors and, in particular, their tyrosine kinase enzyme |
| 07/17/2003 | US20030134864 Famciclovir monohydrate. |
| 07/17/2003 | US20030134840 Novel compounds |
| 07/16/2003 | EP1327631A2 Fused heterocyclic compounds, their production and use as angiotensin II antagonists |
| 07/16/2003 | EP1326864A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 07/16/2003 | EP1326606A2 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 07/16/2003 | CN1430607A Benzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 07/16/2003 | CN1429826A Preparation method and use of sodium Penciclovir sodium hydrate |
| 07/16/2003 | CN1429825A Guanine compound, its preparation method and application |
| 07/15/2003 | US6593332 Phosphodiesterase inhibitors; sexual disorders |
| 07/15/2003 | US6592894 Hydrogel-isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 07/10/2003 | WO2003022274A3 2-aroylimidazole compounds for treating cancer |
| 07/10/2003 | US20030130512 Process for the production of purine derivatives and intermediates therefor |
| 07/10/2003 | US20030130280 Analyzing, prevention blood phosphorylation |
| 07/10/2003 | US20030130236 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 07/09/2003 | EP1324997A2 Dioxolane analogs for improved inter-cellular delivery |
| 07/08/2003 | US6590107 Intermediate 1,3-oxaselenolane lactone |
| 07/08/2003 | US6589950 Treatment of inflammatory or obstructive airways disease for respiratory system disorders |
| 07/03/2003 | WO2002079189A3 Spiroisoquinoline compounds, methods for their preparation and intermediates |
| 07/03/2003 | US20030125342 6-substituted biaryl purine derivatives as potent cyclin/CDK inhibitors and antiproliferative agents |
| 07/02/2003 | EP1322611A1 Chemical compounds |
| 07/02/2003 | EP1322598A1 Nitroso diphenylamine derivatives |
| 07/02/2003 | EP1045849B1 Purine derivatives having phosphodiesterase iv inhibition activity |
| 07/02/2003 | CN1427841A Novel crystal form of 9-substituted hypoxanthine derivatives |
| 07/01/2003 | US6586439 Pharmaceutically active compounds |
| 06/26/2003 | WO2003051882A1 A2a adenosine receptor antagonists |
| 06/26/2003 | WO2003051881A1 Substituted purine nucleoside libraries and compounds by solid-phase combinatorial strategies |
| 06/26/2003 | US20030119878 A 1-arylalkyl-3-aminoalkyl-1,4-dihydropyrid-4-one derivative; sexual disorders; anticarcinogenic agents; benign prostatic hypertrophy/fibroids of the uterus; endometriosis, polycystic ovarian disease, precocious puberty; contraceptives |
| 06/26/2003 | US20030119811 Ion channel antagonists that are NMDA antagonists; treatment of migraine, depression, anxiety, schizophrenia, Parkinson's disease, or stroke. |
| 06/26/2003 | CA2470214A1 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer |
| 06/24/2003 | US6583283 Polymorphic forms of cipamfylline |
| 06/24/2003 | CA2066094C Fused heterocyclic compounds, their production and use |
| 06/19/2003 | US20030114672 Purine inhibitors of protein kinases, G proteins and polymerases |
| 06/19/2003 | US20030114470 Crystalline forms of valacyclovir hydrochloride |
| 06/19/2003 | US20030114468 Psychological disorders |
| 06/19/2003 | US20030114445 Bactericides |
| 06/19/2003 | US20030114375 Method for treating cystic fibrosis |
| 06/18/2003 | EP1319003A1 Xanthine phosphodiesterase v inhibitors |
| 06/18/2003 | EP1318997A1 Pyrazole compounds useful as protein kinase inhibitors |
| 06/18/2003 | EP1318814A2 Triazole compounds useful as protein kinase inhibitors |
| 06/18/2003 | EP1318796A2 Polynucleotide intercalator interceptors and inhibitors |
| 06/18/2003 | EP1015451B1 Tetrahydro gamma-carbolines |
| 06/17/2003 | US6579981 Treating herpes virus |
| 06/17/2003 | US6579894 Bactericides, fungicides |
| 06/17/2003 | US6579868 Purine derivatives and adenosine A2 receptor antagonists serving as preventives/remedies for diabetes |
| 06/12/2003 | WO2003048190A2 Acyclovir-peptide analogs |
| 06/12/2003 | WO2003048161A1 A process for preparing 2,6-dichloropurine |
| 06/12/2003 | WO2003047589A1 Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 06/12/2003 | US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds |
| 06/12/2003 | US20030109484 Novel 2'-halomethylidene, 2'-ethenylidene and 2'ethynyl cytidine, uridine and guanosine derivatives |
| 06/12/2003 | US20030108615 Also comprising a binder, a taste masking layer, a lubricant, and a binder/dissolution enhancer; storage stability; discoloration inhibition; materials handling; easy dosage adjustment |
| 06/12/2003 | CA2466697A1 Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 06/11/2003 | EP1318149A1 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing them |
| 06/11/2003 | EP1317452A1 Pyrazole compounds useful as protein kinase inhibitors |
| 06/11/2003 | EP1317450A1 Pyrazole compounds useful as protein kinase inhibitors |
| 06/11/2003 | EP1317449A1 Pyrazole compounds useful as protein kinase inhibitors |
| 06/11/2003 | EP1317448A1 Pyrazole compounds useful as protein kinase inhibitors |
| 06/11/2003 | EP1317447A1 Pyrazole compounds useful as protein kinase inhibitors |
| 06/11/2003 | EP1317444A1 Pyrazole compounds useful as protein kinase inhibitors |
| 06/11/2003 | EP1054012B1 Purine derivatives and adenosine a2 receptor antagonists serving as preventives/remedies for diabetes |
| 06/10/2003 | US6576776 Method of manufacture of 1,3-oxathiolane nucleosides |
| 06/10/2003 | US6576763 Stereospecific acylation; viricides for herpes and retroviruses |
| 06/10/2003 | CA2303577C Qt dispersion and heart rate variability improvement with crf antagonists to prevent sudden death |
| 06/10/2003 | CA2192354C Corticotropin releasing factor against antagonist |
| 06/05/2003 | WO2002091988A3 Novel processes for the preparation of adenosine compounds and intermediates thereto |
| 06/05/2003 | WO2002036075A3 Small molecule compositions for binding to hsp90 |
| 06/05/2003 | US20030105098 6,9-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines |
| 06/05/2003 | US20030105090 For therapy of cancer, diabetes |
| 06/05/2003 | US20030105077 2,6-Dioxo-1,2,3,6-tetrahydropurine derivatives; dipeptidyl peptidase IV inhibitors for diabetes and obesity |
| 06/05/2003 | US20030105066 For use in producing antiviral, antifungal and antibacterial medicaments |